Adage Capital Partners GP »

First Tracks Biotherapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 729k 20.12

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)

View all positions for Adage Capital Partners GP

Top funds holding First Tracks Biotherapeutics

FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Sanofi
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Arrowstreet Capital, Limited Partnership
Federated Investors
Ally Bridge Group

View all funds holding First Tracks Biotherapeutics